No Preferential Sensitivity of t(8;21) Acute Myeloid Leukemias to Cytosine Arabinoside in Vitro: Is Intensity of Therapy or High Dose Ara-C Crucial for Response?

Giuseppe Visani Department of Hematology, H. San Salvatore, Pesaro, ItalyCorrespondence[email protected]

Alessandro Isidori Institute of Hematology and Medical Oncology “L&A Seragnoli”, Bologna University, Bologna, Italy

Tiziana Grafone Institute of Hematology - Firenze University, Firenze, Italy

Patrizia Tosi Department of Hematology, H. San Salvatore, Pesaro, Italy

Valeria Santini Institute of Hematology and Medical Oncology “L&A Seragnoli”, Bologna University, Bologna, Italy

Michele Malagola Institute of Hematology - Firenze University, Firenze, Italy

Giovanni Martinelli Department of Hematology, H. San Salvatore, Pesaro, Italy

Pier Paolo Piccaluga Institute of Hematology and Medical Oncology “L&A Seragnoli”, Bologna University, Bologna, Italy

Djavid Gaziev Institute of Hematology - Firenze University, Firenze, Italy

Emanuela Ottaviani Department of Hematology, H. San Salvatore, Pesaro, Italy

Giovanni Sparaventi Institute of Hematology and Medical Oncology “L&A Seragnoli”, Bologna University, Bologna, Italy

Sante Tura Institute of Hematology - Firenze University, Firenze, Italy

Related research